165 related articles for article (PubMed ID: 19359233)
41. Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.
Sirikwin S; Likanonsakul S; Waradejwinyoo S; Pattamadilok S; Kumperasart S; Chaovavanich A; Manatsathit S; Malerczyk C; Wasi C
Vaccine; 2009 Jul; 27(32):4350-4. PubMed ID: 19487057
[TBL] [Abstract][Full Text] [Related]
42. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
Huang KH; Loutfy MR; Boulet S; Toma E; Tsoukas CM; Bernard NF
Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
[TBL] [Abstract][Full Text] [Related]
43. Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation.
Molina-Pinelo S; Vallejo A; Díaz L; Soriano-Sarabia N; Ferrando-Martínez S; Resino S; Muñoz-Fernández MA; Leal M
J Antimicrob Chemother; 2009 Sep; 64(3):579-88. PubMed ID: 19608579
[TBL] [Abstract][Full Text] [Related]
44. Antiretroviral Service to HIV patients of low CD4 count in Seti Zonal Hospital.
Paudel BN; Chaudhary SR; Sharma S; Dhungana GP; Paudel P
JNMA J Nepal Med Assoc; 2009; 48(173):24-7. PubMed ID: 19529054
[TBL] [Abstract][Full Text] [Related]
45. [Non-cutaneous manifestations of secondary syphilis].
Dumortier C; Alcaraz I; Tone A; Burban SD; Delesalle F; Maryse F; Melliez H; Viget N; Baclet V; Pavel S; Ajana F; Yazdanpanah Y
Ann Dermatol Venereol; 2008; 135(6-7):451-8. PubMed ID: 18598794
[TBL] [Abstract][Full Text] [Related]
46. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
[TBL] [Abstract][Full Text] [Related]
47. HIV infection and travel: pretravel recommendations and health-related risks.
Franco-Paredes C; Hidron A; Tellez I; Lesesne J; Del Rio C
Top HIV Med; 2009; 17(1):2-11. PubMed ID: 19270343
[TBL] [Abstract][Full Text] [Related]
48. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
[TBL] [Abstract][Full Text] [Related]
49. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.
Rajasekaran S; Raja K; Jeyaseelan L; Vijilat S; Priya K; Mohan K; Parvez A; Mahilmaran A; Chandrasekar C
Indian J Tuberc; 2009 Apr; 56(2):69-76. PubMed ID: 19810588
[TBL] [Abstract][Full Text] [Related]
50. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.
Zoufaly A; Stellbrink HJ; Heiden MA; Kollan C; Hoffmann C; van Lunzen J; Hamouda O;
J Infect Dis; 2009 Jul; 200(1):79-87. PubMed ID: 19476437
[TBL] [Abstract][Full Text] [Related]
51. Malaria infection in HIV/AIDS patients and its correlation with packed cell volume (PCV).
Goselle ON; Onwuliri CO; Onwuliri VA
J Vector Borne Dis; 2009 Sep; 46(3):205-11. PubMed ID: 19724084
[TBL] [Abstract][Full Text] [Related]
52. Ocular surface squamous neoplasia (OSSN) and human immunodeficiency virus at Sekuru Kaguvi Eye Unit in Zimbabwe: the role of operational research studies in a resource poor environment?
Chinogurei TS; Masanganise R; Rusakaniko S; Sibanda E
Cent Afr J Med; 2006; 52(5-6):56-8. PubMed ID: 18254456
[TBL] [Abstract][Full Text] [Related]
53. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
Mihăilescu R; Arama V; Paraschiv S; Streinu-Cercel A; Oţelea D; Munteanu D; Iosipenco M; Chiotan C; Benea OE; Mărdărescu M; Rădulescu M; Hristea A; Ungurianu R; Aramă SS; Cercel AS; Călin R; Băicuş C
Rom J Intern Med; 2008; 46(4):305-11. PubMed ID: 19480296
[TBL] [Abstract][Full Text] [Related]
54. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy.
Chang PE; Miquel R; Blanco JL; Laguno M; Bruguera M; Abraldes JG; Bosch J; Garcia-Pagan JC
Am J Gastroenterol; 2009 Jul; 104(7):1707-14. PubMed ID: 19471257
[TBL] [Abstract][Full Text] [Related]
55. [Attempt to improve the pronostic score of tetanus (author's transl)].
Gallais H; Assad B; Kadio A; Odehouri K; Bissagnene E; Moreau J
Med Trop (Mars); 1979; 39(6):651-5. PubMed ID: 231179
[TBL] [Abstract][Full Text] [Related]
56. Neonatal tetanus in the middle Black Sea region of Turkey.
Totan M; Küçüködük S; Dağdemir A; Dilber C
Turk J Pediatr; 2002; 44(2):139-41. PubMed ID: 12026202
[TBL] [Abstract][Full Text] [Related]
57. Primary oral melanoma associated with HIV infection.
Feller L; Masipa JN; Wood NH; Khamissa RA; Meyerov R; Lemmer J
SADJ; 2008 Feb; 63(1):016-7. PubMed ID: 18543734
[TBL] [Abstract][Full Text] [Related]
58. [Remarks on injuries which were the source of tetanus and were based on observations from the Clinic of Infectious Diseases in Cracow].
Garlicki A; Caban J; Krukowiecki J; Bociaga-Jasik M; Kluba-Wojewoda U
Przegl Lek; 1998; 55(9):448-9. PubMed ID: 10085722
[TBL] [Abstract][Full Text] [Related]
59. The effects of maternal malaria and HIV-1 infection on the effort to eliminate neonatal tetanus.
Moss WJ; Halsey NA
J Infect Dis; 2007 Aug; 196(4):502-4. PubMed ID: 17624833
[No Abstract] [Full Text] [Related]
60. [Review of tetanus points of entry. Study of 229 cases].
Nolla M; Díaz RM; Garcés J; Nolla J
Rev Clin Esp; 1991 Jul; 189(3):101-5. PubMed ID: 1947379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
